EoE Food Desensitization
NCT02881372 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-05-09
Summary
This is a single-center, prospective, pilot clinical trial in which children ages 3-17 years with eosinophilic esophagitis (EoE) who have a known food that triggers EoE flares receive oral desensitization with that specific food antigen, followed by reintroduction of that food into the diet. The purpose of this study is to investigate the safety and feasibility of oral desensitization in children with EoE so that, if determined to be safe, can be repeated on a larger scale to determine efficacy.
Conditions
- Eosinophilic Esophagitis
Interventions
- OTHER
-
Oral food desensitization
The child's specific food antigen will be diluted in a 50% glycerin/water solution containing ascorbic acid (Vitamin C). This oral spray solution will need to be administered twice a day, every day for a total of 4 months
Sponsors & Collaborators
-
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Marc Rhoads, MD · University of Texas
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-08
- Primary Completion
- 2023-05-31
- Completion
- 2023-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
NCT01498497 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
NCT04682639 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
NCT04835168 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
NCT04281108 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Montelukast in Eosinophilic Esophagitis
NCT00511316 ·Status: COMPLETED ·Phase: PHASE1
-
Montelukast in the Treatment of Duodenal Eosinophilia
NCT00148603 ·Status: COMPLETED ·Phase: NA
-
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
NCT07220811 ·Status: RECRUITING ·Phase: PHASE2
-
Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients
NCT02643862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Controlled Trial of Slow Multiallergen Oral Immunotherapy in Young Children
NCT06533462 ·Status: RECRUITING ·Phase: NA
-
Effect of Nasaleze on Nasal Challenge With Allergen
NCT01723397 ·Status: TERMINATED ·Phase: NA
-
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
NCT03191864 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effects and Mechanisms of Yeast Postbiotics on Persistent Allergic Rhinitis Symptoms
NCT07079748 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
NCT01290887 ·Status: TERMINATED ·Phase: PHASE3
-
Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children
NCT02360696 ·Status: COMPLETED
-
Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract
NCT00622362 ·Status: TERMINATED ·Phase: PHASE2
-
Topical Allstate and Nasal Allergen Challenge
NCT01231724 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effect of a Dietary Fatty Acid Supplementation on Symptoms and Bronchial Inflammation in Patients With Asthma
NCT04109534 ·Status: UNKNOWN ·Phase: NA
-
To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge
NCT00881673 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
NCT00407927 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements
NCT00466596 ·Status: COMPLETED ·Phase: PHASE1
-
Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations
NCT05755477 ·Status: UNKNOWN
-
Peanut Allergy Oral Immunotherapy Desensitization
NCT01601522 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
NCT03023397 ·Status: TERMINATED ·Phase: PHASE1
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
NCT00115622 ·Status: COMPLETED ·Phase: PHASE3
-
Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
NCT04046939 ·Status: COMPLETED ·Phase: PHASE2